Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarkers Identification for Diagnosis and Treatment of SARS-COV-2 Infection

NCT04322513 is registered in ClinicalTrials.gov with University of Catanzaro as lead sponsor.

NCT NCT04322513
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04322513 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarkers Identification for Diagnosis and Treatment of SARS-COV-2 Infection
Lead sponsor
University of Catanzaro
Phase
Observational
Overall status
Unknown status
Start date
March 24, 2020
Completion date
December 30, 2022
Enrollment
110 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus